图9 A total of 1696 patients with lung cancer were reviewed, of whom 53 with AIS and 72 with MIAwere included. The RFSs of AIS and MIA were all 100%, and the 10-year OSs of AIS and MIAwere 98.1% and 97.2%, respectively. The risks of developing SPLC for patients with AIS and MIA 10 years after resection were 8.4%and 4.3%, respectively, and were not correlated withEGFRmutation status.
图10 三篇文献概况